Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

They were randomized to either titration of that dose up to 4.5 mg or switched to tirzepatide titrated up to 15 mg (or maximum tolerated doses of both). Most in both groups were also taking oral ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available, according to Mittal. In the 2022 clinical trial, tirzepatide showed ...

Patients with poorly controlled type 2 diabetes despite being on dulaglutide had better outcomes if they switched to tirzepatide than if they upped their dulaglutide dose. In this randomized trial ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Participants given tirzepatide lowered their HbA1c by a mean 0.77% more than those given a higher dulaglutide dose. More tirzepatide participants hit a weight loss threshold known for disease ...

Image credit: NurPhoto/Getty Images. According to a new study, a once-weekly dose of tirzepatide can lead to significant, sustained weight loss for up to 3 years in adults with overweight or ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide.

The trial examined the effect of Eli Lilly’s glucagon-like peptide-1 receptor agonist (GLP-1RA) tirzepatide ... Patients were on a starting dose of 2.5mg/week, which was uptitrated by 2.5mg ...